# Demographics, clinical features, and comorbidities of high-altitude polycythaemia: a multicentre, retrospective, observational study

**Authors:** Mei Yang, Yuxuan Zhu, Lin Liu, Chuanliang Pan, Lifen Li, Qingqing Su, Wenwen Zhou, Linxi Fu, Lin Yang, Fengming Luo, Lei Chen

PMC · DOI: 10.7189/jogh.16.04042 · Journal of Global Health · 2026-01-30

## TL;DR

This study analyzed 1098 high-altitude polycythaemia patients in China, finding higher prevalence in native Tibetans, gender-specific hemoglobin levels, and altitude-related variations.

## Contribution

The study provides the first comprehensive clinical characterization of high-altitude polycythaemia in China, highlighting ethnic and gender-specific patterns.

## Key findings

- Native Tibetans comprised 93% of HAPC patients, indicating a higher prevalence in this ethnic group.
- Hemoglobin levels showed significant gender differences and increased linearly with altitude.
- Comorbidities like hypertension and pneumonia were common, with gender-specific trends in heart and liver diseases.

## Abstract

High altitude polycythaemia (HAPC) has posed a major burden due to its high prevalence and multisystem involvement among highlanders, but clinical data on HAPC is scarce. We aimed to describe the clinical characteristics of patients with HAPC in China.

Adult patients diagnosed with HAPC in five hospitals of China between August 2012 to May 2024 were retrospectively enrolled. We analysed information including demographics, living altitude, haemoglobin concentration (Hb) and comorbidities, and fitted restricted cubic splines models with multivariable adjustments to investigate the relationship between age, altitude and Hb.

A total of 1098 HAPC patients were included and 97 individuals of them did not provide information on ethnicity. Of the remaining 1001 participants, 93% were native Tibetans. The median Hb showed a significant difference (P < 0.0001) between male (21.9 g/dL, interquartile range (IQR) = 21.4–22.9 g/dL) and female patients (19.6 g/dL, IQR = 19.2–20.8 g/dL), and was slightly higher in Tibetans than Han migrants, especially in females (19.6 g/dL, IQR = 19.2–20.7 g/dL vs. 19.3 g/dL, IQR = 19.2–19.5 g/dL) (P = 0.198). Restricted cubic splines models revealed Hb exhibited a positive linear correlation with altitude (P-overall = 0.027, P-nonlinear = 0.291), with a rate of 0.3g/dL/1000 m of elevation, whereas no significant relationship with age (P-overall = 0.974, P-nonlinear = 0.860). The commonest comorbidities were hypertension (18.5%) and pneumonia (17.6%). Besides, heart failure (P < 0.001), chronic airway disease (P = 0.018) and pulmonary heart disease (P < 0.001) were more prominent in females while liver disease (P = 0.079) was more frequent in males.

This study suggests a much higher proportion of HAPC in native Tibetans, and the Hb in HAPC patients remains significant gender-specific and altitude-dependent variations. Moreover, in addition to hypertension and pneumonia, gender-specific comorbidity surveillance should pay attention to digestive system disease in male HAPC patients and cardiopulmonary system disease in female HAPC patients.

## Linked entities

- **Diseases:** pneumonia (MONDO:0005249), heart failure (MONDO:0005252), pulmonary heart disease (MONDO:0004596), liver disease (MONDO:0005154)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** IL3 (interleukin 3) [NCBI Gene 3562] {aka IL-3, MCGF, MULTI-CSF}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, EPO (erythropoietin) [NCBI Gene 2056] {aka DBAL, ECYT5, EP, MVCD2}, EPAS1 (endothelial PAS domain protein 1) [NCBI Gene 2034] {aka ECYT4, HIF2A, HLF, MOP2, PASD2, bHLHe73}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, EGLN1 (egl-9 family hypoxia inducible factor 1) [NCBI Gene 54583] {aka C1orf12, ECYT3, HALAH, HIF-PH2, HIFPH2, HPH-2}, REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}
- **Diseases:** cardiopulmonary disease (MESH:D006323), HAPC (MESH:C535833), asthma (MESH:D001249), chronic bronchitis (MESH:D029481), elevated cardiac output (MESH:D002303), hypoxic (MESH:D002534), Hypertension (MESH:D006973), thrombosis (MESH:D013927), chronic mountain sickness (MESH:D000532), infections (MESH:D007239), polycythaemia (MESH:C548016), Pneumonia (MESH:D011014), EE (MESH:D011086), pulmonary heart disease (MESH:D011660), inflammatory (MESH:D007249), system disease (MESH:D034721), bronchiectasis (MESH:D001987), COPD (MESH:D029424), hypoxia (MESH:D000860), mycobacterial infection (MESH:D009165), cardiopulmonary, liver and gastrointestinal diseases (MESH:D008107), heart failure (MESH:D006333), pulmonary hypertension (MESH:D006976), respiratory infections (MESH:D012141)
- **Chemicals:** iron (MESH:D007501), EE (-), alcohol (MESH:D000438), oxygen (MESH:D010100), testosterone (MESH:D013739)
- **Species:** Mycobacteriales (order) [taxon 85007], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12856962/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12856962/full.md

## References

61 references — full list in the complete paper: https://tomesphere.com/paper/PMC12856962/full.md

---
Source: https://tomesphere.com/paper/PMC12856962